Literature DB >> 3101054

Transient lupus anticoagulant and fansidar therapy.

R F Jeffrey.   

Abstract

A case of the Stevens-Johnson syndrome following Fansidar therapy is reported in which a marked feature was the presence of a circulating anticoagulant of the lupus inhibitor type. Treatment with steroids resulted in complete recovery and disappearance of the anticoagulant.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3101054      PMCID: PMC2422811          DOI: 10.1136/pgmj.62.731.893

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  6 in total

Review 1.  Acquired inhibitors of blood coagulation.

Authors:  D I Feinstein; S I Rapaport
Journal:  Prog Hemost Thromb       Date:  1972

2.  Immunologic and coagulation disorders in chlorpromazine-treated patients.

Authors:  M H Zarrabi; S Zucker; F Miller; R M Derman; G S Romano; J A Hartnett; A O Varma
Journal:  Ann Intern Med       Date:  1979-08       Impact factor: 25.391

3.  Thrombosis, abortion, cerebral disease, and the lupus anticoagulant.

Authors:  G R Hughes
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-15

4.  Thrombosis in patients with the lupus anticoagulant.

Authors:  J R Mueh; K D Herbst; S I Rapaport
Journal:  Ann Intern Med       Date:  1980-02       Impact factor: 25.391

Review 5.  The clotting defect in SLE.

Authors:  M A Byron
Journal:  Clin Rheum Dis       Date:  1982-04

6.  Obstetric complications associated with the lupus anticoagulant.

Authors:  D W Branch; J R Scott; N K Kochenour; E Hershgold
Journal:  N Engl J Med       Date:  1985-11-21       Impact factor: 91.245

  6 in total
  3 in total

Review 1.  Drug-induced lupus anticoagulants and antiphospholipid antibodies.

Authors:  Jeffrey S Dlott; Robert A S Roubey
Journal:  Curr Rheumatol Rep       Date:  2012-02       Impact factor: 4.592

Review 2.  Ascertainment of risk of serious adverse reactions associated with chemoprophylactic antimalarial drugs.

Authors:  P A Phillips-Howard; A B Bjorkman
Journal:  Bull World Health Organ       Date:  1990       Impact factor: 9.408

3.  Patient with both lupus anticoagulant and acute disseminated encephalomyelitis.

Authors:  Y Matsukawa; T Mizutani; N Kitamura; M Takei; T Hayama; S Nishinarita; T Horie; S Sawada; A Tagusagawa; M Tsuchiya; T Takasu
Journal:  Clin Rheumatol       Date:  1996-09       Impact factor: 2.980

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.